Fig. 1From: Application of fluorocarbon nanoparticles of 131I-fulvestrant as a targeted radiation drug for endocrine therapy on human breast cancerSynthesis and identification of 131I-fulvestrant: A Results of paper chromatography for 131I-fulvestrant. B Results of paper chromatography for Na131I control group. C Chemical structure of 131I-fulvestrant. D Mass spectrometry identification results for 131I-fulvestrant. E Molecular sieve column chromatography purification results for 131I-fulvestrant. F Identification of the stability of 131I-fulvestrant at different time points using paper chromatography. (Values are means ± s.d., n = 3)Back to article page